These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18777498)

  • 1. Effects of one-year low-dose growth hormone (GH) therapy on body composition, lipid profile and carbohydrate metabolism in young adults with childhood-onset severe GH deficiency confirmed after completion of growth promotion.
    Hilczer M; Smyczyńska J; Stawerska R; Lewiński A
    Endokrynol Pol; 2008; 59(4):292-300. PubMed ID: 18777498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GH replacement on metabolism and physical performance in GH deficient adults.
    Abdul Shakoor SK; Shalet SM
    J Endocrinol Invest; 2003 Sep; 26(9):911-8. PubMed ID: 14964445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
    Underwood LE; Attie KM; Baptista J;
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Follow-up of Children with Idiopathic Growth Hormone Deficiency After Termination of Growth Hormone Treatment: Is There Really Need for Treatment at Transition to Adulthood?
    Çamtosun E; Şıklar Z; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2018 Jul; 10(3):247-255. PubMed ID: 29553045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
    Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two dose regimens of growth hormone (GH) with different target IGF-1 levels on glucose metabolism, lipid profile, cardiovascular function and anthropometric parameters in gh-deficient adults.
    Cenci MC; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M; Boguszewski CL; Conceição FL
    Growth Horm IGF Res; 2012; 22(3-4):116-21. PubMed ID: 22565153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What happens when growth hormone is discontinued at completion of growth? Metabolic aspects.
    Johannsson G
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1321-6. PubMed ID: 11202204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
    Norrman LL; Johannsson G; Sunnerhagen KS; Svensson J
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2531-8. PubMed ID: 18397981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adiponectin levels in adolescents and young adults with growth hormone deficiency.
    Oswiecimska JM; Roczniak W; Roczniak RG; Malczyk Z; Chyra M; Mazur B; Ziora KT
    Neuro Endocrinol Lett; 2017 May; 38(2):107-116. PubMed ID: 28650604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) secretion in patients with childhood-onset GH deficiency: retesting after one year of therapy and at final height.
    Thomas M; Massa G; Maes M; Beckers D; Craen M; François I; Heinrichs C; Bourguignon JP;
    Horm Res; 2003; 59(1):7-15. PubMed ID: 12566729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.